Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors
Zhipeng Yu, Huizhuo Ji, Juntong Shen, Ruotong Kan, Wenzhu Zhao, Jianrong Li, Long Ding, Jingbo Liu
Abstract
values of 43.32 ± 1.22 μM and 2.27 ± 0.35 mM, respectively. In addition, the inhibition rate of WIR (at a concentration of 1.06 ± 0.87 μM) against BChE was 33.5%, and the peptide WIR was able to simultaneously interact with AChE, BChE, and BACE 1. Residues Ser286 of AChE, Asp70 of BChE, and Thr231, Arg235 of BACE 1 played key roles in the interaction with peptide WIR. In summary, peptide WIR exhibits the potential to be an effective treatment for AD.
Topics & Concepts
ButyrylcholinesteraseAcetylcholinesteraseAchéChemistryCholinesteraseDocking (animal)EnzymeBiochemistryPharmacologyBiologyMedicineNursingComputational Drug Discovery MethodsCholinesterase and Neurodegenerative DiseasesProtein Hydrolysis and Bioactive Peptides